554a0d8581716f391d56b3bc89466a86.jpg

Markforged CEO Shai Terem: “Real growth is coming to AM” Decision Makers

by Technologies

After going public and trading on NYSE since July 2021, Markforged has been releasing detailed data on its performance. For over a decade, all 3D printing stocks have suffered from long periods of decreasing value interrupted by short bursts of very rapid growth. Markforged’s stock has been no different; and yet the company’s growth has been solid, regular and organic, with a “strong balance sheet and a track record of execution to our industry”, as Markforged CEO Shai Terem put it during the latest analyst call on Q1 2022 results when the company reported revenues of $21.9 million and 8.6% YoY growth. 3dpbm had the opportunity to speak with Mr. Terem about Markforged’s latest results, ongoing growth strategy and medium to long-term goals.

Humabiologics partners with Fisher Scientific Bioprinting

Humabiologics Partners with Fisher Scientific Bioprinting

by Medical

Humabiologics, an industry leader in providing human-derived biomaterials for regenerative medicine, founded by scientists and tissue industry experts to address the gap between the gift of donated human tissues and researchers, and Fisher Scientific, a global leader in life sciences, are partnering to serve researchers in academia and industry who are working on regenerative medicine research.

Harry Danford appointed as XJet VP of Sales North America AM Industry

by Business

XJet Ltd. has appointed seasoned AM executive, Harry Danford, as VP of Sales North America, a new role within the business. The appointment is part of a wider strategy to establish a presence and nominate leaders in major regions, with Andy Middleton assigned in Europe and Lior Meron in Asia Pacific. It also adds to the growth across the business as XJet boosts its workforce by 25 percent (since the end of 2021) and makes several other key appointments, with the aim of strengthening its customer collaborations and partnerships.